AXA Investment Managers »

Halozyme Therapeutics shares owned by AXA Investment Managers

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by AXA Investment Managers from 13F filings

Historical chart of AXA Investment Managers investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by AXA Investment Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by AXA Investment Managers

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.6M 131k 73.34